Peptides9 min read
Does pemvidutide preserve muscle? Reading the MRI substudy
Pemvidutide's MRI substudy reported a favorable lean-loss share. Learn what that percentage means and why muscle strength needs separate evidence.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Peptides articles
All articlesMetabolism, recovery and emerging research
Peptides9 min read
What a wound-healing study must report beyond closure time
Closure time matters, but wound studies also need to show who healed, who dropped out, whether wounds reopened and how recovery affected daily life.
Read article
Peptides9 min read
Ipamorelin and muscle gain: what has actually been measured?
A growth hormone pulse is not the same as muscle growth. Understand the animal findings, the human evidence gap, and the difference between lean mass and strength.
Read article
Peptides9 min read
GHRP-6 and hunger: what the appetite research actually shows
GHRP-6 appetite experiments involve rats; human meal studies often cited for it used GHRP-2. Learn what hunger does and does not tell us about benefit.
Read article
Peptides8 min read
LL-37 kills microbes in a laboratory. Why that is not an infection-treatment claim
LL-37 has antimicrobial activity in experiments. Serum, enzymes, host-cell effects and clinical endpoints explain why that is not a treatment claim.
Read article
Peptides9 min read
Mazdutide versus tirzepatide: what their different targets tell us
Both medicines target two hormone receptors, but their clinical trials answer different questions about weight, metabolic health and tolerability.
Read article
Peptides9 min read
Epitalon and cancer cells: what the findings can—and cannot—tell us
Why Epitalon’s effects in breast cancer cell lines matter, how they differ from tumor studies in animals, and why neither establishes human cancer risk.
Read article
Peptides8 min read
Why a gonadorelin stimulation test is not a treatment trial
A gonadorelin challenge measures a short-term pituitary response. Diagnostic accuracy and long-term fertility benefit require different evidence.
Read article
Peptides8 min read
Retatrutide's three receptors: what the glucagon signal adds
Why retatrutide includes glucagon-receptor activity, what animal experiments suggest and which human findings do—and do not—test that mechanism.
Read article
Peptides9 min read
What GHRP-6 combination trials really tell us about peptide stacks
A hospital trial of EGF and GHRP-6 cannot validate an unrelated peptide stack. Here is what its design can tell us about contribution, synergy and safety.
Read article
Peptides9 min read
How to read translated Semax studies without overstating the evidence
A translation can make a study accessible, but it cannot supply missing methods or expand a result beyond the original population and outcome.
Read article
Peptides8 min read
Thymosin alpha-1 is not the same as a thymus extract
A tissue source, a peptide and a finished medicine describe different things. Learn why those distinctions matter when reading thymosin research.
Read article229–240 of 323 articles